RxDoctor Payments Data

Geoffrey Grambau

Pulmonary Disease · Kalamazoo, MINPI 1144324633

Payments from drug & device makers

$2,542in general payments, 2019–2025

Across 200 payments — averaging $12.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$768
  • Boehringer Ingelheim$408
  • AstraZeneca$304
  • Mylan Specialty L.p.$197
  • Genentech USA, Inc.$178
  • Grifols USA, LLC$175
  • plus $512 from 12 others

What the payments were for

  • Food & beverage$2,542100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,542 in reported general payments places this provider in the 55th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Other pulmonary disease in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →